299 related articles for article (PubMed ID: 24590509)
1. T-type calcium channels in chronic pain: mouse models and specific blockers.
François A; Laffray S; Pizzoccaro A; Eschalier A; Bourinet E
Pflugers Arch; 2014 Apr; 466(4):707-17. PubMed ID: 24590509
[TBL] [Abstract][Full Text] [Related]
2. T-type calcium channels in neuropathic pain.
Bourinet E; Francois A; Laffray S
Pain; 2016 Feb; 157 Suppl 1():S15-S22. PubMed ID: 26785151
[TBL] [Abstract][Full Text] [Related]
3. Voltage gated calcium channels as targets for analgesics.
Bourinet E; Zamponi GW
Curr Top Med Chem; 2005; 5(6):539-46. PubMed ID: 16022676
[TBL] [Abstract][Full Text] [Related]
4. Targeting T-type/CaV3.2 channels for chronic pain.
Cai S; Gomez K; Moutal A; Khanna R
Transl Res; 2021 Aug; 234():20-30. PubMed ID: 33422652
[TBL] [Abstract][Full Text] [Related]
5. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
[TBL] [Abstract][Full Text] [Related]
6. Targeting Ca2+ channels to treat pain: T-type versus N-type.
Altier C; Zamponi GW
Trends Pharmacol Sci; 2004 Sep; 25(9):465-70. PubMed ID: 15559248
[TBL] [Abstract][Full Text] [Related]
7. Genetic alteration of the metal/redox modulation of Cav3.2 T-type calcium channel reveals its role in neuronal excitability.
Voisin T; Bourinet E; Lory P
J Physiol; 2016 Jul; 594(13):3561-74. PubMed ID: 26931411
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury.
Yue J; Liu L; Liu Z; Shu B; Zhang Y
Spine (Phila Pa 1976); 2013 Mar; 38(6):463-70. PubMed ID: 22972512
[TBL] [Abstract][Full Text] [Related]
9. Targeting of CaV3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathy.
Todorovic SM; Jevtovic-Todorovic V
Pflugers Arch; 2014 Apr; 466(4):701-6. PubMed ID: 24482063
[TBL] [Abstract][Full Text] [Related]
10. T-Type Channel Druggability at a Crossroads.
Weiss N; Zamponi GW
ACS Chem Neurosci; 2019 Mar; 10(3):1124-1126. PubMed ID: 30697997
[TBL] [Abstract][Full Text] [Related]
11. The Role of Voltage-Gated Sodium Channels in Pain Signaling.
Bennett DL; Clark AJ; Huang J; Waxman SG; Dib-Hajj SD
Physiol Rev; 2019 Apr; 99(2):1079-1151. PubMed ID: 30672368
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of multiple voltage-gated calcium channels may contribute to spinally mediated analgesia by epipregnanolone in a rat model of surgical paw incision.
Joksimovic SL; Donald RR; Park JY; Todorovic SM
Channels (Austin); 2019 Dec; 13(1):48-61. PubMed ID: 30672394
[TBL] [Abstract][Full Text] [Related]
13. T-type voltage-gated calcium channels as targets for the development of novel pain therapies.
Todorovic SM; Jevtovic-Todorovic V
Br J Pharmacol; 2011 Jun; 163(3):484-95. PubMed ID: 21306582
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of interleukin-6 on Ca
Liu Q; Chen W; Fan X; Wang J; Fu S; Cui S; Liao F; Cai J; Wang X; Huang Y; Su L; Zhong L; Yi M; Liu F; Wan Y
Exp Neurol; 2019 Jul; 317():226-243. PubMed ID: 30872136
[TBL] [Abstract][Full Text] [Related]
15. T-type Ca2+ channels as therapeutic targets in the nervous system.
Shin HS; Cheong EJ; Choi S; Lee J; Na HS
Curr Opin Pharmacol; 2008 Feb; 8(1):33-41. PubMed ID: 18203662
[TBL] [Abstract][Full Text] [Related]
16. Loss of T-type calcium current in sensory neurons of rats with neuropathic pain.
McCallum JB; Kwok WM; Mynlieff M; Bosnjak ZJ; Hogan QH
Anesthesiology; 2003 Jan; 98(1):209-16. PubMed ID: 12502999
[TBL] [Abstract][Full Text] [Related]
17. Enhanced T-type calcium channel 3.2 activity in sensory neurons contributes to neuropathic-like pain of monosodium iodoacetate-induced knee osteoarthritis.
Shin SM; Cai Y; Itson-Zoske B; Qiu C; Hao X; Xiang H; Hogan QH; Yu H
Mol Pain; 2020; 16():1744806920963807. PubMed ID: 33054557
[TBL] [Abstract][Full Text] [Related]
18. Analgesic transient receptor potential vanilloid-1-active compounds inhibit native and recombinant T-type calcium channels.
McArthur JR; Finol-Urdaneta RK; Adams DJ
Br J Pharmacol; 2019 Jul; 176(13):2264-2278. PubMed ID: 30927254
[TBL] [Abstract][Full Text] [Related]
19. Distinct inhibition of voltage-activated Ca2+ channels by delta-opioid agonists in dorsal root ganglion neurons devoid of functional T-type Ca2+ currents.
Wu ZZ; Chen SR; Pan HL
Neuroscience; 2008 Jun; 153(4):1256-67. PubMed ID: 18434033
[TBL] [Abstract][Full Text] [Related]
20. Surfen is a broad-spectrum calcium channel inhibitor with analgesic properties in mouse models of acute and chronic inflammatory pain.
Rivas-Ramirez P; Gadotti VM; Zamponi GW; Weiss N
Pflugers Arch; 2017 Oct; 469(10):1325-1334. PubMed ID: 28664409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
